Wikipedia:Version 1.0 Editorial Team/COVID-19 articles by quality log
 | This is a log of operations by a bot. The contents of this page are unlikely to need human editing. In particular, links should not be disambiguated as this is a historical record. |
May 14, 2024[edit]
Reassessed[edit]
May 13, 2024[edit]
Removed[edit]
- Draft:Lamont Daigle (talk) removed.
May 10, 2024[edit]
Assessed[edit]
- Fluvoxamine (talk) assessed. Quality assessed as B-Class. (rev · t) Importance assessed as Low-Class. (rev · t)
- Impact of the COVID-19 pandemic on consumer products (talk) assessed. Quality assessed as Unassessed-Class. (rev · t) Importance assessed as Unknown-Class. (rev · t)
Removed[edit]
- Draft:Christos Garoufis (talk) removed.